{"pub": "fox", "url": "https://foxbusiness.com/healthcare/walgreens-joins-rite-aid-and-cvs-in-pulling-zantac-from-shelves", "downloaded_at": "2019-10-01 11:44:28.525754+00:00", "title": "Walgreens joins Rite Aid and CVS in pulling Zantac from shelves", "language": "en", "text": "Walgreens joins what has now become a pharmacy trifecta in pulling the stop selling the heartburn medicine Zantac and its generic versions from store shelves.\n\nContinue Reading Below\n\nWalgreens joins Rite Aid and CVS after the Food and Drug Administration warned this month that it had detected low levels of a cancer-causing chemical in samples of the drug, according to the New York Times.\n\nWalgreens and CVS announced its move on Saturday.\n\nTicker Security Last Change Change % WBA WALGREENS BOOTS ALLIANCE INC. 55.31 +0.90 +1.65% CVS CVS HEALTH CORPORATION 63.07 +0.99 +1.59% RAD RITE AID 6.95 -0.33 -4.53%\n\nThe companies said customers who had bought the products could return them for a refund.\n\nThe F.D.A. is looking into the source of the contamination as well as the risk to patients.\n\nCLICK HERE TO READ MORE ON FOX BUSINESS\n\nZantac, the brand-name version of the drug, is sold by Sanofi, but generic versions are widely sold.", "description": "The companies said customers who had bought the products could return them for a refund.", "authors": ["Ken Martin"], "top_image": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2019/09/0/0/zantac-iStock.jpg?ve=1&tl=1", "published_at": "2019-10-01"}